Robert Palmisano has joined SV Life Sciences as a venture partner. He most recently served as CEO of IntraLase, which was acquired by Advanced Medical Optics earlier this year for over $800 million.
SV Life Sciences Advisers, LLC (“SVLS”) today announced that Robert J. Palmisano has joined the firm as a venture partner. Mr. Palmisano was most recently Chief Executive Officer and Director of IntraLase (Nasdaq:ILSE), which was acquired by Advanced Medical Optics (NYSE:EYE) earlier this year in a transaction totaling over $800 million.
“We are very pleased to have Bob join our team to help increase our depth in the MedTech sector,” said David Milne, Managing Partner of SVLS. “Bob is a proven entrepreneurial leader in building companies and managing teams to build shareholder value. As a Venture Partner, we look forward to being able to use his experience to partner with entrepreneurs and management teams in sourcing and fostering new portfolio companies, particularly those in later stages of development.”
“I am delighted to become a member of the SVLS team, a firm that I see as a premier investor in the health care space,” said Mr. Palmisano. “As someone engaged in the healthcare industry since the late 1980s, I am very pleased to contribute my own experience and knowledge towards the success of SVLS's current and new portfolio companies.”
Mr. Palmisano was formerly president, CEO and a director of IntraLase Corp. from April 2003 to May 2007, prior to that company's acquisition. From April 2001 to April 2003, he was the president, CEO and a director of MacroChem Corporation, a development-stage pharmaceutical corporation. From April 1997 to January 2001, he served as president and CEO and a director of Summit Autonomous, Inc., a global medical products company that was acquired by Alcon, Inc. in October 2000, in a transaction nearing $1 billion. Prior to 1997, he held various executive positions with Bausch & Lomb Incorporated, a global eye care company. Mr. Palmisano currently is a director of Advanced Medical Optics, Inc. (NYSE:EYE), Osteotech, Inc. (Nasdaq:OSTE) and Orometrix, Inc. Mr. Palmisano earned his bachelor's degree from
SV Life Sciences Advisers, LLC (“SVLS”) is a life sciences-focused venture capital adviser and manager. SVLS advised or managed funds that invest in companies requiring funding within the human life sciences sector including biotechnology and pharmaceuticals, medical devices and instruments, healthcare IT and services. SVLS advises or manages four venture capital funds and a publicly traded investment trust with total capital of approximately $1.6 billion that invest in life sciences companies at all stages of development. SVLS has 28 professionals and has invested in over 175 companies over the course of the last decade making SVLS one of the largest and most active healthcare investors in the world. SVLS was established in 1993 and currently has offices in Boston, San Francisco and London. For more information, please visit the company's website at www.svlsa.com .